The Food and Drug Administration on ... Patients who carry two copies of the Alzheimer's risk gene, ApoE4, are more likely to get ARIA-related side effects. The FDA said people should take a ...

Biogen BIIB announced that the FDA has granted fast track designation to its investigational Alzheimer's disease (AD ... this designation is to ‘get important new drugs to the patient earlier.’ ...

Read full article: Blanco deals 8 scoreless innings as Astros dominate Reds on Mother’s Day, take weekend series Read full article: Houston Police are investigating a deadly shooting on Mainer ...

Eli Lilly finally has FDA approval for its amyloid-busting Alzheimer’s disease ... drugs, but potentially life-threatening. It could also face a strong challenge if Eisai and Biogen get approval ...

A new study has found that a common class of medications could dramatically decrease the risk of developing the neurodegenerative disorder.

So, what’s really going on? In early 2023, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new Alzheimer’s drug called Leqembi. (Biogen, a biotechnology company ...

“She said, ‘You know, you’ve been slipping a little bit, maybe you should get a test ... The last drug to be approved by the FDA for Alzheimer’s was in 2003 — and that was just ...

Alzheimer’s disease stands as the most widespread ... that nucleoside reverse transcriptase inhibitors (NRTIs), drugs already FDA-approved for treating HIV and hepatitis B, could suppress ...

There are 164,000 people in Virginia age 65 and older who suffer from Alzheimer’s, but two new drugs approved by the Food and Drug Administration could offer hope to those in the early ...